Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helmut Friess

Showing results (551-560 of 770) with videos related to

Pageof 77
Sort By:
International Journal of Cancer|July 9, 2005
FXYD3 is overexpressed in pancreatic ductal adenocarcinoma and influences pancreatic cancer cell growthHany Kayed, Jörg Kleeff, Armin Kolb, et al.
Plos One|July 13, 2017
BRG1 promotes hepatocarcinogenesis by regulating proliferation and invasivenessBenedikt Kaufmann, Baocai Wang, Suyang Zhong, et al.
Neoplasia (New York, N.Y.)|November 22, 2007
15-lipoxygenase-1 production is lost in pancreatic cancer and overexpression of the gene inhibits tumor cell growthRené Hennig, Timo Kehl, Seema Noor, et al.
BMC Cancer|March 17, 2006
Corticosteroid co-treatment induces resistance to chemotherapy in surgical resections, xenografts and established cell lines of pancreatic cancerChengwen Zhang, Armin Kolb, Peter Büchler, et al.
Langenbeck'S Archives of Surgery|March 1, 2008
R2 resection in pancreatic cancer--does it make sense?Jörg Köninger, Moritz N Wente, Beat P Müller-Stich, et al.
International Journal of Cancer|October 29, 2024
ARP2/3 complex affects myofibroblast differentiation and migration in pancreatic ductal adenocarcinomaYifeng Sun, Yina Qiao, Yiqi Niu, et al.
JCI Insight|January 11, 2022
Targeting the undruggable oncogenic KRAS: the dawn of hopeHande Asimgil, Utku Ertetik, Nedim Can Çevik, et al.
Annals of Surgery|December 6, 2005
The Notch signaling pathway is related to neurovascular progression of pancreatic cancerPeter Büchler, Amiq Gazdhar, Mario Schubert, et al.
Gut|October 19, 2006
The neurotrophic factor artemin influences the extent of neural damage and growth in chronic pancreatitisGüralp O Ceyhan, Frank Bergmann, Mustafa Kadihasanoglu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|June 10, 2026
Paclitaxel and triptolide impair MYC-driven cell cycle via suppressing chromatin reprogramming in ALDH1A3<sup>High</sup> pancreatic cancerShuang Nie, Yihang Jiang, Lingxi Meng, et al.
Pageof 77

Showing results (551-560 of 770) with videos related to

Sort By:
Pageof 77
International Journal of Cancer|July 9, 2005
FXYD3 is overexpressed in pancreatic ductal adenocarcinoma and influences pancreatic cancer cell growthHany Kayed, Jörg Kleeff, Armin Kolb, et al.
Plos One|July 13, 2017
BRG1 promotes hepatocarcinogenesis by regulating proliferation and invasivenessBenedikt Kaufmann, Baocai Wang, Suyang Zhong, et al.
Neoplasia (New York, N.Y.)|November 22, 2007
15-lipoxygenase-1 production is lost in pancreatic cancer and overexpression of the gene inhibits tumor cell growthRené Hennig, Timo Kehl, Seema Noor, et al.
BMC Cancer|March 17, 2006
Corticosteroid co-treatment induces resistance to chemotherapy in surgical resections, xenografts and established cell lines of pancreatic cancerChengwen Zhang, Armin Kolb, Peter Büchler, et al.
Langenbeck'S Archives of Surgery|March 1, 2008
R2 resection in pancreatic cancer--does it make sense?Jörg Köninger, Moritz N Wente, Beat P Müller-Stich, et al.
International Journal of Cancer|October 29, 2024
ARP2/3 complex affects myofibroblast differentiation and migration in pancreatic ductal adenocarcinomaYifeng Sun, Yina Qiao, Yiqi Niu, et al.
JCI Insight|January 11, 2022
Targeting the undruggable oncogenic KRAS: the dawn of hopeHande Asimgil, Utku Ertetik, Nedim Can Çevik, et al.
Annals of Surgery|December 6, 2005
The Notch signaling pathway is related to neurovascular progression of pancreatic cancerPeter Büchler, Amiq Gazdhar, Mario Schubert, et al.
Gut|October 19, 2006
The neurotrophic factor artemin influences the extent of neural damage and growth in chronic pancreatitisGüralp O Ceyhan, Frank Bergmann, Mustafa Kadihasanoglu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|June 10, 2026
Paclitaxel and triptolide impair MYC-driven cell cycle via suppressing chromatin reprogramming in ALDH1A3<sup>High</sup> pancreatic cancerShuang Nie, Yihang Jiang, Lingxi Meng, et al.
Pageof 77